chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Headache, Hyperhidrosis, Nausea, Pain
Clinical narrative: Headache every day; Nauseous; Vomiting; Sweats and chills; sweats and chills; Extreme body pain; Dizzy; Short of breath; irregular ECG readings; Extremely tired; Visual problems; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0162), via an unspecified route of administration, administered in right arm on 14Apr2021 09:00 (50-year-old at time of vaccination) as single dose for COVID-19 immunization. Medical history included systemic lupus and IGg deficien. Concomitant medications included morphine (MORPHINE); oxycodone (OXYCODONE); cyclobenzaprine hydrochloride (FLEXERIL); belimumab (BENLYSTA); and "Gammagua" (unspecified). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EP7534), via an unspecified route of administration, administered in left arm on 24Mar2021 09:00 (50-year-old at time of vaccination) as single dose for COVID-19 immunization. The patient previously received atorvastatin (LIPITOR) and experienced "Known allergies: Lipitor"; previously received zolmitriptan (ZOMIG) and experienced "Known allergies: zomig"; previously received primidone and experienced "Known allergies: primidone". The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in Public Health Clinic. Adverse event from 14Apr2021 18:00: Within 24 hours of 2nd dose and until this date of 08Jul2021 the patient has had ongoing and variations in severity multiple symptoms to including but not limited to: headache every day, nauseous, vomiting, sweats and chills, extreme body pain, dizzy, short of breath, she's had irregular ECG readings, and extremely tired, visual problems. The events were assessed as serious with criteria of Disabling/Incapacitating. The adverse event result in doctor or other healthcare professional office/clinic visit, and disability or permanent damage. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The outcome of the events was not recovered.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Visual impairment, Vomiting
Clinical narrative: Headache every day; Nauseous; Vomiting; Sweats and chills; sweats and chills; Extreme body pain; Dizzy; Short of breath; irregular ECG readings; Extremely tired; Visual problems; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0162), via an unspecified route of administration, administered in right arm on 14Apr2021 09:00 (50-year-old at time of vaccination) as single dose for COVID-19 immunization. Medical history included systemic lupus and IGg deficien. Concomitant medications included morphine (MORPHINE); oxycodone (OXYCODONE); cyclobenzaprine hydrochloride (FLEXERIL); belimumab (BENLYSTA); and "Gammagua" (unspecified). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EP7534), via an unspecified route of administration, administered in left arm on 24Mar2021 09:00 (50-year-old at time of vaccination) as single dose for COVID-19 immunization. The patient previously received atorvastatin (LIPITOR) and experienced "Known allergies: Lipitor"; previously received zolmitriptan (ZOMIG) and experienced "Known allergies: zomig"; previously received primidone and experienced "Known allergies: primidone". The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in Public Health Clinic. Adverse event from 14Apr2021 18:00: Within 24 hours of 2nd dose and until this date of 08Jul2021 the patient has had ongoing and variations in severity multiple symptoms to including but not limited to: headache every day, nauseous, vomiting, sweats and chills, extreme body pain, dizzy, short of breath, she's had irregular ECG readings, and extremely tired, visual problems. The events were assessed as serious with criteria of Disabling/Incapacitating. The adverse event result in doctor or other healthcare professional office/clinic visit, and disability or permanent damage. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The outcome of the events was not recovered.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Fatigue, Headache
Clinical narrative: Headache every day; Nauseous; Vomiting; Sweats and chills; sweats and chills; Extreme body pain; Dizzy; Short of breath; irregular ECG readings; Extremely tired; Visual problems; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0162), via an unspecified route of administration, administered in right arm on 14Apr2021 09:00 (50-year-old at time of vaccination) as single dose for COVID-19 immunization. Medical history included systemic lupus and IGg deficien. Concomitant medications included morphine (MORPHINE); oxycodone (OXYCODONE); cyclobenzaprine hydrochloride (FLEXERIL); belimumab (BENLYSTA); and "Gammagua" (unspecified). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EP7534), via an unspecified route of administration, administered in left arm on 24Mar2021 09:00 (50-year-old at time of vaccination) as single dose for COVID-19 immunization. The patient previously received atorvastatin (LIPITOR) and experienced "Known allergies: Lipitor"; previously received zolmitriptan (ZOMIG) and experienced "Known allergies: zomig"; previously received primidone and experienced "Known allergies: primidone". The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in Public Health Clinic. Adverse event from 14Apr2021 18:00: Within 24 hours of 2nd dose and until this date of 08Jul2021 the patient has had ongoing and variations in severity multiple symptoms to including but not limited to: headache every day, nauseous, vomiting, sweats and chills, extreme body pain, dizzy, short of breath, she's had irregular ECG readings, and extremely tired, visual problems. The events were assessed as serious with criteria of Disabling/Incapacitating. The adverse event result in doctor or other healthcare professional office/clinic visit, and disability or permanent damage. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The outcome of the events was not recovered.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hyperhidrosis, Nausea, Pain, Vomiting
Clinical narrative: Headache every day; Nauseous; Vomiting; Sweats and chills; sweats and chills; Extreme body pain; Dizzy; Short of breath; irregular ECG readings; Extremely tired; Visual problems; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0162), via an unspecified route of administration, administered in right arm on 14Apr2021 09:00 (50-year-old at time of vaccination) as single dose for COVID-19 immunization. Medical history included systemic lupus and IGg deficien. Concomitant medications included morphine (MORPHINE); oxycodone (OXYCODONE); cyclobenzaprine hydrochloride (FLEXERIL); belimumab (BENLYSTA); and "Gammagua" (unspecified). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EP7534), via an unspecified route of administration, administered in left arm on 24Mar2021 09:00 (50-year-old at time of vaccination) as single dose for COVID-19 immunization. The patient previously received atorvastatin (LIPITOR) and experienced "Known allergies: Lipitor"; previously received zolmitriptan (ZOMIG) and experienced "Known allergies: zomig"; previously received primidone and experienced "Known allergies: primidone". The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in Public Health Clinic. Adverse event from 14Apr2021 18:00: Within 24 hours of 2nd dose and until this date of 08Jul2021 the patient has had ongoing and variations in severity multiple symptoms to including but not limited to: headache every day, nauseous, vomiting, sweats and chills, extreme body pain, dizzy, short of breath, she's had irregular ECG readings, and extremely tired, visual problems. The events were assessed as serious with criteria of Disabling/Incapacitating. The adverse event result in doctor or other healthcare professional office/clinic visit, and disability or permanent damage. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The outcome of the events was not recovered.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Chest X-ray, Chills, Computerised tomogram, Decreased appetite
Clinical narrative: Developed myocarditis two days after his second Pfizer vaccine; This is a spontaneous report from a contactable consumer. This consumer (patient's mother) reported for son that, A 18-year-old male adolescent patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 08Jun2021 as a DOSE 2, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received bnt162b2 (PFIZ-ER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 18May2021 as a DOSE 1, SINGLE for covid-19 immunization. Patient had sore arm after dose 1. The patient developed myocarditis two days after his second pfizer vaccine on 10Jun2021. The patient was hospitalized for developing myocarditis two days after his second pfizer vaccine from 10Jun2021 to an unknown date. Patient was hospitalized with myocarditis on 10Jun2021 two days after his second dose of Pfizer's COVID vaccine. Felt pressured at work by his employer and co-workers to get vaccinated. "They were uncomfortable that he wasn't vaccinated" reporter stated. "So he got the COVID vaccine without telling me." Withheld other son, now 16, had an adverse reaction to his measlesmumps rubella (MMR) vaccine when he was younger, and has not been vaccinated since. After first Pfizer dose on May18 he experienced a sore arm but was otherwise ok. Teen suffers severe heart damage after second Pfizer Dose, mother Says Hospital 'Clueless' About Reporting to VAERS Withheld whose 18-year-old son developed myocarditis two days after his second Pfizer vaccine, said she would never have connected the dots between the vaccine and patient's symptoms if she hadn't read about the condition. Dataset of 53 records, Found were sore arm. adverse reaction. COVID, myocarditis, measles, measles mumps, rubella, sore, MMR vaccine. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram, Electrocardiogram, Fatigue, Headache, Laboratory test
Clinical narrative: Developed myocarditis two days after his second Pfizer vaccine; This is a spontaneous report from a contactable consumer. This consumer (patient's mother) reported for son that, A 18-year-old male adolescent patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 08Jun2021 as a DOSE 2, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received bnt162b2 (PFIZ-ER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 18May2021 as a DOSE 1, SINGLE for covid-19 immunization. Patient had sore arm after dose 1. The patient developed myocarditis two days after his second pfizer vaccine on 10Jun2021. The patient was hospitalized for developing myocarditis two days after his second pfizer vaccine from 10Jun2021 to an unknown date. Patient was hospitalized with myocarditis on 10Jun2021 two days after his second dose of Pfizer's COVID vaccine. Felt pressured at work by his employer and co-workers to get vaccinated. "They were uncomfortable that he wasn't vaccinated" reporter stated. "So he got the COVID vaccine without telling me." Withheld other son, now 16, had an adverse reaction to his measlesmumps rubella (MMR) vaccine when he was younger, and has not been vaccinated since. After first Pfizer dose on May18 he experienced a sore arm but was otherwise ok. Teen suffers severe heart damage after second Pfizer Dose, mother Says Hospital 'Clueless' About Reporting to VAERS Withheld whose 18-year-old son developed myocarditis two days after his second Pfizer vaccine, said she would never have connected the dots between the vaccine and patient's symptoms if she hadn't read about the condition. Dataset of 53 records, Found were sore arm. adverse reaction. COVID, myocarditis, measles, measles mumps, rubella, sore, MMR vaccine. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Pain, Pericarditis, Pyrexia
Clinical narrative: Developed myocarditis two days after his second Pfizer vaccine; This is a spontaneous report from a contactable consumer. This consumer (patient's mother) reported for son that, A 18-year-old male adolescent patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 08Jun2021 as a DOSE 2, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received bnt162b2 (PFIZ-ER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 18May2021 as a DOSE 1, SINGLE for covid-19 immunization. Patient had sore arm after dose 1. The patient developed myocarditis two days after his second pfizer vaccine on 10Jun2021. The patient was hospitalized for developing myocarditis two days after his second pfizer vaccine from 10Jun2021 to an unknown date. Patient was hospitalized with myocarditis on 10Jun2021 two days after his second dose of Pfizer's COVID vaccine. Felt pressured at work by his employer and co-workers to get vaccinated. "They were uncomfortable that he wasn't vaccinated" reporter stated. "So he got the COVID vaccine without telling me." Withheld other son, now 16, had an adverse reaction to his measlesmumps rubella (MMR) vaccine when he was younger, and has not been vaccinated since. After first Pfizer dose on May18 he experienced a sore arm but was otherwise ok. Teen suffers severe heart damage after second Pfizer Dose, mother Says Hospital 'Clueless' About Reporting to VAERS Withheld whose 18-year-old son developed myocarditis two days after his second Pfizer vaccine, said she would never have connected the dots between the vaccine and patient's symptoms if she hadn't read about the condition. Dataset of 53 records, Found were sore arm. adverse reaction. COVID, myocarditis, measles, measles mumps, rubella, sore, MMR vaccine. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis
Clinical narrative: Developed myocarditis two days after his second Pfizer vaccine; This is a spontaneous report from a contactable consumer. This consumer (patient's mother) reported for son that, A 18-year-old male adolescent patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 08Jun2021 as a DOSE 2, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received bnt162b2 (PFIZ-ER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 18May2021 as a DOSE 1, SINGLE for covid-19 immunization. Patient had sore arm after dose 1. The patient developed myocarditis two days after his second pfizer vaccine on 10Jun2021. The patient was hospitalized for developing myocarditis two days after his second pfizer vaccine from 10Jun2021 to an unknown date. Patient was hospitalized with myocarditis on 10Jun2021 two days after his second dose of Pfizer's COVID vaccine. Felt pressured at work by his employer and co-workers to get vaccinated. "They were uncomfortable that he wasn't vaccinated" reporter stated. "So he got the COVID vaccine without telling me." Withheld other son, now 16, had an adverse reaction to his measlesmumps rubella (MMR) vaccine when he was younger, and has not been vaccinated since. After first Pfizer dose on May18 he experienced a sore arm but was otherwise ok. Teen suffers severe heart damage after second Pfizer Dose, mother Says Hospital 'Clueless' About Reporting to VAERS Withheld whose 18-year-old son developed myocarditis two days after his second Pfizer vaccine, said she would never have connected the dots between the vaccine and patient's symptoms if she hadn't read about the condition. Dataset of 53 records, Found were sore arm. adverse reaction. COVID, myocarditis, measles, measles mumps, rubella, sore, MMR vaccine. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Stent placement, Thrombectomy, Thrombosis
Clinical narrative: Fainting spell; blood clot; low heart rate for extended period of time; This is a spontaneous report from contactable consumer (patient). A 61-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 09Apr2021 09:30 (Batch/Lot Number: EW0162) as dose 2, single for Covid-19 immunization. The patient received the 1st dose of Comirnaty (Lot number: ER8727) on 19Mar2021 09:30 AM (at the age of 61years) in left arm for Covid-19 Immunization (no reaction). Medical history included femoral artery aneurysm from Jan2020 to an unknown date. Concomitant medications included atorvastatin calcium (ATORVASTATIN CALCIUM) taken for an unspecified indication, start and stop date were not reported; and acetylsalicylic acid (ASAPRIN) taken for an unspecified indication, start and stop date were not reported. The patient previously took codeine and experienced hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 28May2021 16:00, the patient experienced fainting spell, blood clot, and low heart rate for extended period of time. The patient was hospitalized for the events for 6 days. The events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The treatment received for the adverse events included Stent inserted and heart rate monitor implanted. The patient has not been tested for COVID-19 since the vaccination. The outcome of events was recovered with sequel on an unspecified date. Seriousness criteria was reported as hospitalization, life threatening illness (immediate risk of death from the event), disability or permanent damage].
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Heart rate decreased, Syncope, Thrombosis
Clinical narrative: Fainting spell; blood clot; low heart rate for extended period of time; This is a spontaneous report from contactable consumer (patient). A 61-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 09Apr2021 09:30 (Batch/Lot Number: EW0162) as dose 2, single for Covid-19 immunization. The patient received the 1st dose of Comirnaty (Lot number: ER8727) on 19Mar2021 09:30 AM (at the age of 61years) in left arm for Covid-19 Immunization (no reaction). Medical history included femoral artery aneurysm from Jan2020 to an unknown date. Concomitant medications included atorvastatin calcium (ATORVASTATIN CALCIUM) taken for an unspecified indication, start and stop date were not reported; and acetylsalicylic acid (ASAPRIN) taken for an unspecified indication, start and stop date were not reported. The patient previously took codeine and experienced hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 28May2021 16:00, the patient experienced fainting spell, blood clot, and low heart rate for extended period of time. The patient was hospitalized for the events for 6 days. The events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The treatment received for the adverse events included Stent inserted and heart rate monitor implanted. The patient has not been tested for COVID-19 since the vaccination. The outcome of events was recovered with sequel on an unspecified date. Seriousness criteria was reported as hospitalization, life threatening illness (immediate risk of death from the event), disability or permanent damage].
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris
Clinical narrative: sharp pain on his heart; patient had a mini pain attack on his heart that felt like having a heart attack or so; This is a spontaneous report from a contactable consumer (patient). A 30-year old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in left arm on 22Jun2021 16:45 (Batch/Lot Number: EW0178) at the age of 30 years as single dose for covid-19 immunisation. Patient had no medical history and past drug history. Concomitant medications included finasteride; minoxidil (MINOXIDIL (FOR MEN)); ascorbic acid, biotin, calcium, equisetum arvense stem, ferrous fumarate, nicotinamide, panicum miliaceum seed, proteins nos, shark cartilage (VIVISCAL ADVANCED HAIR HEALTH). Historical vaccine included the first dose of BNT162B2 (Batch/lot number : EW0175) in left arm on 15May2021 at the age of 30 years for covid-19 immunisation. Patient had no other vaccines within 4 weeks prior to the COVID vaccine. The day after his 2nd shot (Day 1) 23Jun2021, 08:00 he woke up with a very sharp pain on his heart. The pain got worse and was permanent. On Day 2 patient had a mini pain attack on his heart that felt like having a heart attack or so. It was a very sharp pain and lasted about 20 minutes. The pain remained for another couple of days until it went away. Now, around 18 days after his 2nd shot, he just had another pain attack on his heart that lasted a few minutes. Prior to vaccination, patient was not diagnosed with COVID-19. Nasal Swab on 01Jul2021 was negative. Outcome of events were unknown.  Follow-up attempts are completed. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris, Myocardial infarction, SARS-CoV-2 antibody test
Clinical narrative: sharp pain on his heart; patient had a mini pain attack on his heart that felt like having a heart attack or so; This is a spontaneous report from a contactable consumer (patient). A 30-year old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in left arm on 22Jun2021 16:45 (Batch/Lot Number: EW0178) at the age of 30 years as single dose for covid-19 immunisation. Patient had no medical history and past drug history. Concomitant medications included finasteride; minoxidil (MINOXIDIL (FOR MEN)); ascorbic acid, biotin, calcium, equisetum arvense stem, ferrous fumarate, nicotinamide, panicum miliaceum seed, proteins nos, shark cartilage (VIVISCAL ADVANCED HAIR HEALTH). Historical vaccine included the first dose of BNT162B2 (Batch/lot number : EW0175) in left arm on 15May2021 at the age of 30 years for covid-19 immunisation. Patient had no other vaccines within 4 weeks prior to the COVID vaccine. The day after his 2nd shot (Day 1) 23Jun2021, 08:00 he woke up with a very sharp pain on his heart. The pain got worse and was permanent. On Day 2 patient had a mini pain attack on his heart that felt like having a heart attack or so. It was a very sharp pain and lasted about 20 minutes. The pain remained for another couple of days until it went away. Now, around 18 days after his 2nd shot, he just had another pain attack on his heart that lasted a few minutes. Prior to vaccination, patient was not diagnosed with COVID-19. Nasal Swab on 01Jul2021 was negative. Outcome of events were unknown.  Follow-up attempts are completed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: 7/08/21 within 5 mintues of vaccination pt became lightheaded, dizzy, nauseaus and complaining of vertigo while sitting down outside the pharmacy window.  gave 2 glucose tablets,  15 min later pt still felt the same symptoms, blood pressure was taken systolic over 150 HR remained in the low 70s. 15 min later pt still felt the same symptoms, blood pressure was taken systolic over 160 cool pack placed on pt neck, remained in sitting position. Another 15 min past granola snack given, pt blood pressure systolic still over 160 with normal sinus rhythm in the 70s, nausea subsided, pt still feeling vertigo and lightheadness.  Another 15 min past systolic blood pressure over 150, pt complaining of vertigo and feeling weird, unable to stand alone.  Family member came to pick up pt due to complaint of vertigo and dizziness. Everyday after the 8th of July to present day this patient has had vertigo without movement along with transient numbness and tingling of right side of face. No treatment taken 7/20 MD notified of vertigo awaiting response 7/23 MD interviewed pt and prescribed medication for vertigo and recommended to report reaction to vaccine.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure systolic increased, Dizziness, Dysstasia, Feeling abnormal, Hypoaesthesia
Clinical narrative: 7/08/21 within 5 mintues of vaccination pt became lightheaded, dizzy, nauseaus and complaining of vertigo while sitting down outside the pharmacy window.  gave 2 glucose tablets,  15 min later pt still felt the same symptoms, blood pressure was taken systolic over 150 HR remained in the low 70s. 15 min later pt still felt the same symptoms, blood pressure was taken systolic over 160 cool pack placed on pt neck, remained in sitting position. Another 15 min past granola snack given, pt blood pressure systolic still over 160 with normal sinus rhythm in the 70s, nausea subsided, pt still feeling vertigo and lightheadness.  Another 15 min past systolic blood pressure over 150, pt complaining of vertigo and feeling weird, unable to stand alone.  Family member came to pick up pt due to complaint of vertigo and dizziness. Everyday after the 8th of July to present day this patient has had vertigo without movement along with transient numbness and tingling of right side of face. No treatment taken 7/20 MD notified of vertigo awaiting response 7/23 MD interviewed pt and prescribed medication for vertigo and recommended to report reaction to vaccine.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Paraesthesia, Vertigo
Clinical narrative: 7/08/21 within 5 mintues of vaccination pt became lightheaded, dizzy, nauseaus and complaining of vertigo while sitting down outside the pharmacy window.  gave 2 glucose tablets,  15 min later pt still felt the same symptoms, blood pressure was taken systolic over 150 HR remained in the low 70s. 15 min later pt still felt the same symptoms, blood pressure was taken systolic over 160 cool pack placed on pt neck, remained in sitting position. Another 15 min past granola snack given, pt blood pressure systolic still over 160 with normal sinus rhythm in the 70s, nausea subsided, pt still feeling vertigo and lightheadness.  Another 15 min past systolic blood pressure over 150, pt complaining of vertigo and feeling weird, unable to stand alone.  Family member came to pick up pt due to complaint of vertigo and dizziness. Everyday after the 8th of July to present day this patient has had vertigo without movement along with transient numbness and tingling of right side of face. No treatment taken 7/20 MD notified of vertigo awaiting response 7/23 MD interviewed pt and prescribed medication for vertigo and recommended to report reaction to vaccine.
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Echocardiogram, Inflammation, Magnetic resonance imaging abdominal, Nerve conduction studies
Clinical narrative: began with tingling of feet; swelling of feet, then swelling of both legs; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 86-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6201), via an unspecified route of administration, administered in Arm Left on 22Feb2021 10:00 (at the age of 86-year-old) as dose 2, single for covid-19 immunisation.  Medical history included, osteoarthritis from an unknown date and unknown if ongoing, scoliosis from an unknown date and unknown if ongoing, stoma closure from an unknown date and unknown if ongoing, drug hypersensitivity to penicillin and cipro, rubber sensitivity from an unknown date and unknown if ongoing. Patient was not pregnant at the time of vaccination. Concomitant medications included pantoprazole taken for an unspecified indication, start and stop date were not reported; metoprolol taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9263), via an unspecified route of administration, administered in Arm Left on 30Jan2021 10:00 (at the age of 86-year-old) as dose 1, single for covid-19 immunisation. On 28Feb2021, the patient experienced, began with tingling of feet then swelling of feet, then swelling of both legs. Therapeutic measures taken as a result of events included prednisone, diuretics. The events resulted in doctor or other healthcare professional office/clinic visit, Disability or permanent damage. Reporter assessed the events as serious, Disabling/Incapacitating. The outcome of the events were not recovered.
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Paraesthesia, Peripheral swelling, Ultrasound Doppler
Clinical narrative: began with tingling of feet; swelling of feet, then swelling of both legs; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 86-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6201), via an unspecified route of administration, administered in Arm Left on 22Feb2021 10:00 (at the age of 86-year-old) as dose 2, single for covid-19 immunisation.  Medical history included, osteoarthritis from an unknown date and unknown if ongoing, scoliosis from an unknown date and unknown if ongoing, stoma closure from an unknown date and unknown if ongoing, drug hypersensitivity to penicillin and cipro, rubber sensitivity from an unknown date and unknown if ongoing. Patient was not pregnant at the time of vaccination. Concomitant medications included pantoprazole taken for an unspecified indication, start and stop date were not reported; metoprolol taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9263), via an unspecified route of administration, administered in Arm Left on 30Jan2021 10:00 (at the age of 86-year-old) as dose 1, single for covid-19 immunisation. On 28Feb2021, the patient experienced, began with tingling of feet then swelling of feet, then swelling of both legs. Therapeutic measures taken as a result of events included prednisone, diuretics. The events resulted in doctor or other healthcare professional office/clinic visit, Disability or permanent damage. Reporter assessed the events as serious, Disabling/Incapacitating. The outcome of the events were not recovered.
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Paraesthesia, Peripheral swelling
Clinical narrative: began with tingling of feet; swelling of feet, then swelling of both legs; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 86-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6201), via an unspecified route of administration, administered in Arm Left on 22Feb2021 10:00 (at the age of 86-year-old) as dose 2, single for covid-19 immunisation.  Medical history included, osteoarthritis from an unknown date and unknown if ongoing, scoliosis from an unknown date and unknown if ongoing, stoma closure from an unknown date and unknown if ongoing, drug hypersensitivity to penicillin and cipro, rubber sensitivity from an unknown date and unknown if ongoing. Patient was not pregnant at the time of vaccination. Concomitant medications included pantoprazole taken for an unspecified indication, start and stop date were not reported; metoprolol taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9263), via an unspecified route of administration, administered in Arm Left on 30Jan2021 10:00 (at the age of 86-year-old) as dose 1, single for covid-19 immunisation. On 28Feb2021, the patient experienced, began with tingling of feet then swelling of feet, then swelling of both legs. Therapeutic measures taken as a result of events included prednisone, diuretics. The events resulted in doctor or other healthcare professional office/clinic visit, Disability or permanent damage. Reporter assessed the events as serious, Disabling/Incapacitating. The outcome of the events were not recovered.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Diagnosed with Herpes Zoster (Shingles); This is a spontaneous report from a contactable consumer (patient). A 63-years-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EW0178) via an unspecified route of administration, administered in arm left on 20May2021 as dose 2, single for COVID-19 immunization. Age at the time of vaccination was 63 years. Medical history included had donated blood on 20Mar2021 (about one month prior to my first COVID vaccine). The patient concomitant medications were not reported. Patient had no known allergies. Previously patient received first dose of bnt162b2 (BNT162B2; Solution for injection, Batch/Lot Number: EW0175) via an unspecified route of administration, administered in arm left on 27Apr2021 as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced rash started on 09Jul2021. Diagnosed with Herpes Zoster (Shingles) on 11Jul at (withheld) by (name withheld). She did not believe it was related to the vaccine, but she wanted to report due to seeing other shingles cases being reported after receiving Covid vaccines. She had read that donating blood can lead to temporary drops in certain immune cells (Serum protein and antibodies). Perhaps people should not donate blood before getting vaccinated. The patient received Valacyclovir 1000mg as treatment for adverse event. The outcome of the event was recovering.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Scan with contrast normal, Tinnitus
Clinical narrative: After four days of flu-like symptoms which began on evening of second Pfizer vaccine experienced hearing loss and Tinnitus.Diagnosis: sudden right-sided hearing loss and tinnitus (ICD-H91.20 and ICD; After four days of flu-like symptoms which began on evening of second Pfizer vaccine experienced hearing loss and Tinnitus.Diagnosis: sudden right-sided hearing loss and tinnitus (ICD-H91.20 and ICD; After four days of flu-like symptoms which began on evening of second Pfizer vaccine experienced hearing loss and Tinnitus.Diagnosis: sudden right-sided hearing loss and tinnitus (ICD-H91.20 and ICD; This is a spontaneous report from a contactable consumer. A 65-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot Number: EL3247), dose 2 via an unspecified route of administration in left arm on 16Feb2021 at 14:00 (at the age of 65-years-old) as second dose, single for COVID-19 immunization. Medical history included thyroid cancer and diverticulitis. Concomitant medications included liothyronine sodium (CYTOMEL), levothyroxine sodium (SYNTHYROID), bupropion (BUPROPION). The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of bnt162b2 (Lot number: EL1284) in left arm on 26Jan2021 at 02:00 PM for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Feb2021 at 19:00 PM, after four days of flu-like symptoms which began on evening of second Pfizer vaccine, patient experienced hearing loss and tinnitus. Diagnosis was sudden right-sided hearing loss and tinnitus (icd-h91.20 and icd-h93.11). The adverse event result in doctor or other healthcare professional office/clinic visit. Primary Care Doctor, 04Mar2021 prescribed ZPAC and asked if no improvement see ENT. There was no improvement, hence ENT Appointment on18Mar2021, doctor prescribed high dose Prednisone beginning with 60 mg for five days and titration after from 18Mar2021 to 08Apr2021. Also conducted audiological evaluation which indicated moderate to severe Sensorineural Hearing Loss (SNHL) in right ear. Ordered MRI with contrast. There was other ENT Appointments with Dr on 25Mar2021, 06Apr2021 and 10May21. Second Opinion ENT with Dr. who conducted audiologic evaluation and performed prednisone injection into right ear on 12May2021. Follow-up ENT appointment with Dr. on 09Jun2021 in which he referred her to an Otolaryngologists, Dr. who said cochlear implant was the solution. The patient received treatment with ZPAC, Prednisone 20 days and ear injection steroid. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included audiological evaluation: moderate to severe Sensorineural Hearing Loss (SNHL) in right ear on an unspecified date of Mar2021; PCR: negative on 11-JUN-2021 and Antigen: Nasal Swab: Negative on 19Jun2021. The outcome of the event was not recovered.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Audiogram, Deafness, Influenza like illness, SARS-CoV-2 test, Tinnitus
Clinical narrative: After four days of flu-like symptoms which began on evening of second Pfizer vaccine experienced hearing loss and Tinnitus.Diagnosis: sudden right-sided hearing loss and tinnitus (ICD-H91.20 and ICD; After four days of flu-like symptoms which began on evening of second Pfizer vaccine experienced hearing loss and Tinnitus.Diagnosis: sudden right-sided hearing loss and tinnitus (ICD-H91.20 and ICD; After four days of flu-like symptoms which began on evening of second Pfizer vaccine experienced hearing loss and Tinnitus.Diagnosis: sudden right-sided hearing loss and tinnitus (ICD-H91.20 and ICD; This is a spontaneous report from a contactable consumer. A 65-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot Number: EL3247), dose 2 via an unspecified route of administration in left arm on 16Feb2021 at 14:00 (at the age of 65-years-old) as second dose, single for COVID-19 immunization. Medical history included thyroid cancer and diverticulitis. Concomitant medications included liothyronine sodium (CYTOMEL), levothyroxine sodium (SYNTHYROID), bupropion (BUPROPION). The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of bnt162b2 (Lot number: EL1284) in left arm on 26Jan2021 at 02:00 PM for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Feb2021 at 19:00 PM, after four days of flu-like symptoms which began on evening of second Pfizer vaccine, patient experienced hearing loss and tinnitus. Diagnosis was sudden right-sided hearing loss and tinnitus (icd-h91.20 and icd-h93.11). The adverse event result in doctor or other healthcare professional office/clinic visit. Primary Care Doctor, 04Mar2021 prescribed ZPAC and asked if no improvement see ENT. There was no improvement, hence ENT Appointment on18Mar2021, doctor prescribed high dose Prednisone beginning with 60 mg for five days and titration after from 18Mar2021 to 08Apr2021. Also conducted audiological evaluation which indicated moderate to severe Sensorineural Hearing Loss (SNHL) in right ear. Ordered MRI with contrast. There was other ENT Appointments with Dr on 25Mar2021, 06Apr2021 and 10May21. Second Opinion ENT with Dr. who conducted audiologic evaluation and performed prednisone injection into right ear on 12May2021. Follow-up ENT appointment with Dr. on 09Jun2021 in which he referred her to an Otolaryngologists, Dr. who said cochlear implant was the solution. The patient received treatment with ZPAC, Prednisone 20 days and ear injection steroid. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included audiological evaluation: moderate to severe Sensorineural Hearing Loss (SNHL) in right ear on an unspecified date of Mar2021; PCR: negative on 11-JUN-2021 and Antigen: Nasal Swab: Negative on 19Jun2021. The outcome of the event was not recovered.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Menstrual disorder, Thrombosis
Clinical narrative: I used to have my menses, my period only a few time a year and very light and four days after the vaccine I started bleeding very heavily for two weeks and then every month since then I bleed for two to three weeks, very heavy blood loss; I used to have my menses, my period only a few time a year and very light and four days after the vaccine I started bleeding very heavily for two weeks and then every month since then I bleed for two to three weeks, very heavy blood loss; I used to have my menses, my period only a few time a year and very light and four days after the vaccine I started bleeding very heavily for two weeks and then every month since then I bleed for two to three weeks, very heavy blood loss; This is a spontaneous report from a contactable consumer (patient). A 33-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration date was not reported), via an unspecified route of administration at the age 0f 33-year-old on 08Apr2021 as dose1, single for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient stated, she needed to report a side effect from the vaccine. Four days after her first dose, so the 12Apr. She had her first dose on 8Apr and 12Apr was first day of the side effect. She stated She used to have her menses, her period only a few times a year and very light and four days after the vaccine she started bleeding very heavily for two weeks and then every month since then she bleeds for two to three weeks, very heavy blood loss. The clinical outcome of events was unknown.  Information on the lot/batch number has been requested.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haemorrhage, Heavy menstrual bleeding, Oligomenorrhoea
Clinical narrative: I used to have my menses, my period only a few time a year and very light and four days after the vaccine I started bleeding very heavily for two weeks and then every month since then I bleed for two to three weeks, very heavy blood loss; I used to have my menses, my period only a few time a year and very light and four days after the vaccine I started bleeding very heavily for two weeks and then every month since then I bleed for two to three weeks, very heavy blood loss; I used to have my menses, my period only a few time a year and very light and four days after the vaccine I started bleeding very heavily for two weeks and then every month since then I bleed for two to three weeks, very heavy blood loss; This is a spontaneous report from a contactable consumer (patient). A 33-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration date was not reported), via an unspecified route of administration at the age 0f 33-year-old on 08Apr2021 as dose1, single for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient stated, she needed to report a side effect from the vaccine. Four days after her first dose, so the 12Apr. She had her first dose on 8Apr and 12Apr was first day of the side effect. She stated She used to have her menses, her period only a few times a year and very light and four days after the vaccine she started bleeding very heavily for two weeks and then every month since then she bleeds for two to three weeks, very heavy blood loss. The clinical outcome of events was unknown.  Information on the lot/batch number has been requested.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Brain death, Computerised tomogram head abnormal, Fall, Fatigue, Fibrin D dimer
Clinical narrative: Intracerebral hemorrhage while skiing on 2/19/21. Progressed to unresponsiveness. Declared brain dead and removed from life support. 2/20/21
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haemorrhage intracranial, Headache, Intensive care, Laboratory test normal, Loss of consciousness
Clinical narrative: Intracerebral hemorrhage while skiing on 2/19/21. Progressed to unresponsiveness. Declared brain dead and removed from life support. 2/20/21